Dividends & Income
To screen ETFs by asset class, performance, yield and more, check out the
disagrees with FDA, and decides they will continue with 306 study on its own terms. Not a sound business model...
bit oversimplified what you write there.
Add a reply...
Latest StockTalks »
people get EXEL breaking news and analysis by email alert.
Get email alerts on EXEL »
Get latest price
From other sites
Is Exelixis (EXEL) Stock a Solid Choice Right Now? - Tale of the Tape
at Zacks.com (Mar 18, 2015)
Exelixis (EXEL) Shares March Higher, Can It Continue? - Tale of the Tape
at Zacks.com (Feb 27, 2015)
Will Exelixis (EXEL) Miss Estimates this Earnings Season? - Analyst Blog
at Zacks.com (Feb 23, 2015)
Exelixis Data Release Upcoming; Options Activity Spiking
at Benzinga.com (Feb 5, 2015)
Best biotech trades on ASH meeting: Kensho
at CNBC.com (Dec 8, 2014)
Xignite quote data
© 2015 Seeking Alpha